|
GeneEd's database of disease-state e-learning
addresses the top 40 diseases and top 10 therapeutic areas pursued by
pharmaceutical, biotechnology, medical device, and health care organizations.
San Francisco, CA, May 22nd, 2006 —
GeneEd, Inc., the leading provider of e-Learning solutions for the life
science and health care industries, announced today that it has delivered
more than 130 new e-Learning courses covering the anatomy, physiology,
epidemiology, pathophysiology, prognosis, and diagnosis and treatment
of a comprehensive list of disease states, ranging from atrial fibrillation
to small-cell lung cancer (http://www.geneed.com/catalog/ta.html).
This database of disease-state training represents one of the most comprehensive
catalogs of animated expositions created in medical health. Over five
years in the making, GeneEd sought global validation for each content
item from top scientific and medical experts within various medical schools
and universities. The content was also validated with major pharmaceutical
and biotechnology companies. Each course, divided by up to four sections,
consists of 20-30 lessons. Each lesson is a shareable content object (SCO),
reusable by GeneEd, its partners, and its clients as part of the exciting
new paradigm in dynamic learning content delivery.
Unlike the 'roll-and-scroll' static text and images commonly found at
major e-health sites, GeneEd's Therapeutic Area database consists of dynamic
Flash®-based animations, which incorporate lucid expositions of disease
state processes. The animations are annotated with voice-overs, PDF transcripts,
and linked to a glossary. (While the courses are currently available in
U.S. English, GeneEd has expertise in localization to European and Asian
languages and intends to release multiple language versions in the future.)
The courses include progress-checks, quizzes, and a final assessment so
learners can gauge their progress and understanding as they navigate the
content. New lesson-objects have been added to GeneEd's content library
of several thousand learning objects. More than 100 new Web pages describing
the courses have been uploaded to GeneEd's Web site, available at: http://www.geneed.com/catalog/ta.html.
In addition to the new "off-the-shelf" courses that GeneEd
provides, each shareable content object (or 'learning' object) can be
rapidly assembled into customized courses based upon a client's specifications.
This flexibility allows custom-specific courseware to be provided in an
extremely cost-effective and timely manner. Customers already using GeneEd's
disease-state database include AstraZeneca, Amgen, Pfizer, Roche, Organon,
Genentech, and many others. Business partners who have commenced distributing
the database with their own products and services include Campbell Alliance,
RWD Technologies, Perkin-Elmer Life, and Analytical Sciences.
The new disease-state database includes courses in the following therapeutic areas:
- Cardiovascular System
- Central Nervous System
- Diabetes
- Gastrointestinal System
- Infectious Diseases
- Musculoskeletal System
- Oncology
- Pain
- Respiratory System
- Urology
"The Disease-State and Therapeutic Area library addresses a growing need
within pharmaceutical companies to educate employees in modern, biomolecular
medicine that the new therapeutics are designed to address," said Dr.
Sunil Maulik, GeneEd's co-founder. "While numerous academic organizations
provide an excellent foundation for fundamental medical science, none
have been effective at creating compelling e-Learning validated for commercial
use. We are changing that today by utilizing our Repurposing™ and Viewing™
engines and deep-domain expertise to deliver dynamic, compelling, disease-state
e-Learning to pharmaceutical, biotechnology and health care employees
worldwide. As we continue to expand and update our content, we expect
our industry-validated disease-state database to remain the standard for
many years to come."
All GeneEd catalog and custom courseware is Continuing Medical Education
(CME) Category One accredited and approved. GeneEd's curricula also allows
rapid technical integration into any organization's Learning Management
System (LMS). All GeneEd e-Learning courses and learning objects are SCORM
1.2 compliant, and have been successfully integrated within 21 CFR Part
11-compliant applications.
About GeneEd
GeneEd, Inc. was founded in 1997 to provide life science and health care
e-Learning solutions for the pharmaceutical, biotechnology, instrument,
medical device, and hospital/HMO industries. GeneEd's life science industry
customers include AstraZeneca, Accenture, Amgen, GE-Healthcare, Pfizer,
Johnson & Johnson, Roche, Sanofi-Aventis, Bio-Rad, Mayne Pharma and Genentech,
among others (http://www.geneed.com/customers.html).
GeneEd utilizes the best life science content, combined with advanced
e-Learning development technology, to rapidly create basic and advanced
curricula in the areas of genomics, disease state, drug discovery
and development, pharmacogenomics, bioinformatics, and therapeutic
and diagnostic products. GeneEd, Inc. is a privately held company
headquartered in San Francisco, California. Visit http://www.GeneEd.com
for additional information about GeneEd and its courseware.
(Flash is a trademark of Macromedia Corp/Adobe Inc.)
|
